Skip to main content
Top
Published in: Clinical Rheumatology 3/2012

01-03-2012 | Original Article

Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus

Authors: Gang Wang, Lai-Shan Tam, Bonnie Ching-Ha Kwan, Edmund Kwok-Ming Li, Kai-Ming Chow, Cathy Choi-Wan Luk, Philip Kam-Tao Li, Cheuk-Chun Szeto

Published in: Clinical Rheumatology | Issue 3/2012

Login to get access

Abstract

We studied the levels of miR-146a and miR-155 in the urine sediment of SLE patients. The levels of miR-146a and miR-155 in the urine sediment of 40 SLE patients who were receiving calcitriol treatment and 13 healthy controls were determined with real-time quantitative polymerase chain reaction. The levels of urinary miR-146a and miR-155 in patients with SLE were significantly higher than that in healthy controls. Calcitriol treatment reduced the levels of urinary miR-155 in patients with SLE. The level of urinary miR-146a significantly correlated with estimated glomerular filtration rate (r = 0.242, P = 0.008). The level of urinary miR-155 significantly correlated with proteinuria (r = 0.407, P < 0.001) and systemic lupus erythematosus disease activity index (r = 0.278, P = 0.002). The level of urinary miR-146a reversely correlated with the urinary expression of TNF-α (r = −0.247, P = 0.012). Our results suggested that miR-146a and miR-155 might play important roles in the pathophysiology of SLE and the levels of urinary miR-146a and miR-155 could be used as potential markers for diagnosis, disease activity, and therapeutic response.
Literature
1.
go back to reference Cook HT, Botto M (2006) Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:330–337PubMedCrossRef Cook HT, Botto M (2006) Mechanisms of disease: the complement system and the pathogenesis of systemic lupus erythematosus. Nat Clin Pract Rheumatol 2:330–337PubMedCrossRef
3.
go back to reference Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501–537PubMedCrossRef Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y (2004) Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 34:501–537PubMedCrossRef
4.
5.
go back to reference Zhang B, Farwell MA (2008) microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 12:3–21PubMedCrossRef Zhang B, Farwell MA (2008) microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 12:3–21PubMedCrossRef
6.
go back to reference Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32:189–194PubMedCrossRef Pauley KM, Cha S, Chan EK (2009) MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32:189–194PubMedCrossRef
7.
go back to reference Lu LF, Liston A (2009) MicroRNA in the immune system, microRNA as an immune system. Immunology 127:291–298PubMedCrossRef Lu LF, Liston A (2009) MicroRNA in the immune system, microRNA as an immune system. Immunology 127:291–298PubMedCrossRef
8.
go back to reference Liang TJ, Qin CY (2009) The emerging role of microRNAs in immune cell development and differentiation. APMIS 117:635–643PubMedCrossRef Liang TJ, Qin CY (2009) The emerging role of microRNAs in immune cell development and differentiation. APMIS 117:635–643PubMedCrossRef
9.
go back to reference Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH et al (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16:939–946PubMedCrossRef Dai Y, Huang YS, Tang M, Lv TY, Hu CX, Tan YH et al (2007) Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16:939–946PubMedCrossRef
10.
go back to reference Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y (2009) Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29:749–754PubMedCrossRef Dai Y, Sui W, Lan H, Yan Q, Huang H, Huang Y (2009) Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 29:749–754PubMedCrossRef
11.
go back to reference Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60:1065–1075PubMedCrossRef Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y et al (2009) MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60:1065–1075PubMedCrossRef
12.
go back to reference Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470PubMed
13.
go back to reference Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36:1211–1215PubMedCrossRef Williams AE, Perry MM, Moschos SA, Larner-Svensson HM, Lindsay MA (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem Soc Trans 36:1211–1215PubMedCrossRef
14.
go back to reference Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792:497–505PubMed Faraoni I, Antonetti FR, Cardone J, Bonmassar E (2009) miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792:497–505PubMed
15.
go back to reference Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:R101–R102PubMedCrossRef Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:R101–R102PubMedCrossRef
16.
go back to reference Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE et al (2008) Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58:1001–1009PubMedCrossRef Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE et al (2008) Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58:1001–1009PubMedCrossRef
17.
go back to reference Chan EK, Satoh M, Pauley KM (2009) Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum 60:912–915PubMedCrossRef Chan EK, Satoh M, Pauley KM (2009) Contrast in aberrant microRNA expression in systemic lupus erythematosus and rheumatoid arthritis: is microRNA-146 all we need? Arthritis Rheum 60:912–915PubMedCrossRef
19.
go back to reference Xiao C, Rajewsky K (2009) MicroRNA control in the immune system: basic principles. Cell 136:26–36PubMedCrossRef Xiao C, Rajewsky K (2009) MicroRNA control in the immune system: basic principles. Cell 136:26–36PubMedCrossRef
20.
go back to reference Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412PubMedCrossRef Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404–412PubMedCrossRef
21.
go back to reference Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P et al (2009) Phenotypic and functional markers for 1alpha, 25-dihydroxyvitamin d(3)-modified regulatory dendritic cells. Clin Exp Immunol 157:48–59PubMedCrossRef Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P et al (2009) Phenotypic and functional markers for 1alpha, 25-dihydroxyvitamin d(3)-modified regulatory dendritic cells. Clin Exp Immunol 157:48–59PubMedCrossRef
22.
go back to reference Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA (2009) Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 583:3349–3355PubMedCrossRef Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA (2009) Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in human alveolar epithelial cells. FEBS Lett 583:3349–3355PubMedCrossRef
23.
go back to reference Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS et al (2009) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773–6784CrossRef Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS et al (2009) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28:6773–6784CrossRef
24.
go back to reference Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC (2004) Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 50:2882–2890PubMedCrossRef Chan RW, Lai FM, Li EK, Tam LS, Wong TY, Szeto CY, Li PK, Szeto CC (2004) Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 50:2882–2890PubMedCrossRef
25.
go back to reference Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Lai KB, Li PK, Szeto CC (2007) Intra-renal cytokine gene expression in lupus nephritis. Ann Rheum Dis 66:886–892PubMedCrossRef Chan RW, Lai FM, Li EK, Tam LS, Chow KM, Lai KB, Li PK, Szeto CC (2007) Intra-renal cytokine gene expression in lupus nephritis. Ann Rheum Dis 66:886–892PubMedCrossRef
26.
go back to reference Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC (2011) Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20:493–500PubMedCrossRef Wang G, Tam LS, Li EK, Kwan BC, Chow KM, Luk CC, Li PK, Szeto CC (2011) Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 20:493–500PubMedCrossRef
Metadata
Title
Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus
Authors
Gang Wang
Lai-Shan Tam
Bonnie Ching-Ha Kwan
Edmund Kwok-Ming Li
Kai-Ming Chow
Cathy Choi-Wan Luk
Philip Kam-Tao Li
Cheuk-Chun Szeto
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 3/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1857-4

Other articles of this Issue 3/2012

Clinical Rheumatology 3/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine